Murepavadin

Indicaton

Hospital-acquired pneumonia
Ventilator-associated pneumonia

Therapeutic indications

Infectious disease

Type of product

Table

Phase

Phase III started

You may also be interested in

Regkirona (regdanvimab)

Regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (COVID-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19

Marketed

Cadazolid

Crohn's disease

Phase II started

Zevtera / Mabelio (ceftobiprole)

Acute bacterial skin and skin structure infections (ABSSSI)

Phase III completed